Compare Davita Inc (DVA) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Target Corporation — how do they compare? Davita Inc trades at $180.24 (market cap $11.38B), while Target Corporation trades at $153.27 (market cap $69.17B). The key difference: Target Corporation is far larger — about 6.1× Davita Inc's market cap, and Target Corporation pays a 3.05% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | TGT | |
|---|---|---|
Market Cap | $11.38B | $69.17B |
Sector | Health | Consumer Cyclical |
52-Week High | $240.96 | $152.35 |
52-Week Low | $103.87 | $83.68 |
Enterprise Value | $24.10B | $84.47B |
Dividend Yield | — | 3.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $180.25, down 1.87% amid mixed signals. The stock shows strong earnings momentum with three consecutive quarterly beats (Q4 2025-Q2 2026) but faces margin pressure. Technical indicators are conflicted with a bullish overall signal but bearish moving averages. Revenue growth remains steady, climbing from $11.6B in 2022 to $13.6B in 2025, though net income margin fluctuated between 4.82% and 7.3% over the same period.
The outlook is cautiously optimistic with a $232.25 consensus price target offering 29% upside. Key risks include reimbursement pressure and high debt levels (debt-to-asset ratio of 65.55% in 2025). Analyst sentiment leans neutral (56.52% Hold) despite recent earnings strength, reflecting concerns about payer mix and margin sustainability.
Target Corporation (TGT) trades at $152.85, up 0.5% today, near its 52-week high. The stock shows strong momentum with bullish technical signals and consistent earnings beats in recent quarters. Revenue remains stable around $106 billion, with a net income margin of 3.24% and solid cash flow from operations of $7.37 billion in 2025. Recent news includes the appointment of a chief AI officer, highlighting strategic focus on technology.
The outlook is positive with analyst consensus leaning buy, though valuation multiples like P/E of 20.12 suggest fair pricing. Risks include competitive retail pressures and macroeconomic sensitivity. Upside potential exists if AI initiatives drive efficiency, but investors should monitor Q2 2026 earnings for confirmation of growth trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
